Skip to main content

Table 1 Susceptibilities to additional antimicrobials stratified by carbapenem susceptibility

From: Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study

Drug Carbapenem-S Carbapenem-NS
S R I NR S R I NR
Cefepime 31 17 2 0 1 74 1 0
Ciprofloxacin 27 17 5 1 0 74 1 1
Gentamycin 37 10 2 1 31 34 10 1
Piperacillin-Tazobactam 22 16 9 3 1 71 3 1
Tobramycin 19 1 0 30 28 20 8 20
Trimethoprim-Sulfamethoxazole 34 13 2 1 8 67 0 1
Amikacin 3 1 0 46 27 20 5 24
Ampicillin-Sulbactam 0 0 2 48 4 16 19 37
Aztreonam 1 0 0 46 41 0 0 35
Colistin 4 0 0 46 53 0 0 23
Minocycline 2 2 0 46 20 24 8 24
Tygecycline 0 2 0 48 5 7 17 47
Doxycycline 0 2 0 48 19 19 2 36
  1. S = susceptible, NS = non-susceptible, R = resistant, I = intermediate, NR = not reported.